Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Antithrombin concentrate use in children: a multicenter cohort study.

Wong TE, Huang YS, Weiser J, Brogan TV, Shah SS, Witmer CM.

J Pediatr. 2013 Nov;163(5):1329-34.e1. doi: 10.1016/j.jpeds.2013.06.036. Epub 2013 Aug 6.

2.

Antithrombin concentrates use in children on extracorporeal membrane oxygenation: a retrospective cohort study.

Wong TE, Delaney M, Gernsheimer T, Matthews DC, Brogan TV, Mazor R, McMullan DM, Reiner AP, Konkle BA.

Pediatr Crit Care Med. 2015 Mar;16(3):264-9. doi: 10.1097/PCC.0000000000000322.

PMID:
25581634
3.

Off-label recombinant factor VIIa use and thrombosis in children: a multi-center cohort study.

Witmer CM, Huang YS, Lynch K, Raffini LJ, Shah SS.

J Pediatr. 2011 May;158(5):820-825.e1. doi: 10.1016/j.jpeds.2010.10.038. Epub 2010 Dec 10.

4.

Antithrombin concentrate in pediatric patients requiring unfractionated heparin anticoagulation: a retrospective cohort study.

Ryerson LM, Bauman ME, Kuhle S, Bruce AA, Massicotte MP.

Pediatr Crit Care Med. 2014 Oct;15(8):e340-6. doi: 10.1097/PCC.0000000000000174.

PMID:
24901804
5.

Accuracy of the all patient refined diagnosis related groups classification system in congenital heart surgery.

Parnell AS, Shults J, Gaynor JW, Leonard MB, Dai D, Feudtner C.

Ann Thorac Surg. 2014 Feb;97(2):641-50. doi: 10.1016/j.athoracsur.2013.08.012. Epub 2013 Nov 5.

6.

Off-label drug use in hospitalized children.

Shah SS, Hall M, Goodman DM, Feuer P, Sharma V, Fargason C Jr, Hyman D, Jenkins K, White ML, Levy FH, Levin JE, Bertoch D, Slonim AD.

Arch Pediatr Adolesc Med. 2007 Mar;161(3):282-90. Erratum in: Arch Pediatr Adolesc Med. 2007 Jul;161(7):655.

PMID:
17339510
7.

Extracorporeal membrane oxygenation in children after repair of congenital cardiac lesions.

Aharon AS, Drinkwater DC Jr, Churchwell KB, Quisling SV, Reddy VS, Taylor M, Hix S, Christian KG, Pietsch JB, Deshpande JK, Kambam J, Graham TP, Chang PA.

Ann Thorac Surg. 2001 Dec;72(6):2095-101; discussion 2101-2.

PMID:
11789800
8.

Off-label use of cardiovascular medications in children hospitalized with congenital and acquired heart disease.

Pasquali SK, Hall M, Slonim AD, Jenkins KJ, Marino BS, Cohen MS, Shah SS.

Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):74-83. doi: 10.1161/CIRCOUTCOMES.108.787176. Epub 2008 Nov 5.

9.

Significant increase in clopidogrel use across U.S. children's hospitals.

Gentilomo C, Huang YS, Raffini L.

Pediatr Cardiol. 2011 Feb;32(2):167-75. doi: 10.1007/s00246-010-9836-0. Epub 2010 Dec 7.

PMID:
21132568
10.

Intraoperative extracorporeal membrane oxygenation and survival of pediatric patients undergoing repair of congenital heart disease.

Flick RP, Sprung J, Gleich SJ, Barnes RD, Warner DO, Dearani JA, Scott PD, Hanson AC, Schroeder DR, Schears GJ.

Paediatr Anaesth. 2008 Aug;18(8):757-66. doi: 10.1111/j.1460-9592.2008.02632.x.

PMID:
18544147
11.

20-year experience of prolonged extracorporeal membrane oxygenation in critically ill children with cardiac or pulmonary failure.

Gupta P, McDonald R, Chipman CW, Stroud M, Gossett JM, Imamura M, Bhutta AT.

Ann Thorac Surg. 2012 May;93(5):1584-90. doi: 10.1016/j.athoracsur.2012.01.008. Epub 2012 Mar 14.

PMID:
22421589
12.

The impact of extracorporeal membrane oxygenation on survival in pediatric patients with acute respiratory failure. Pediatric Critical Care Study Group.

Green TP, Timmons OD, Fackler JC, Moler FW, Thompson AE, Sweeney MF.

Crit Care Med. 1996 Feb;24(2):323-9.

PMID:
8605808
13.

Neutrophil gelatinase-associated lipocalin levels during extracorporeal membrane oxygenation in critically ill children with congenital heart disease: preliminary experience.

Ricci Z, Morelli S, Favia I, Garisto C, Brancaccio G, Picardo S.

Pediatr Crit Care Med. 2012 Jan;13(1):e51-4. doi: 10.1097/PCC.0b013e3181fe4717.

PMID:
21057360
14.

Leveraging administrative data to monitor rituximab use in 2875 patients at 42 freestanding children's hospitals across the United States.

Kavcic M, Fisher BT, Seif AE, Li Y, Huang YS, Walker D, Aplenc R.

J Pediatr. 2013 Jun;162(6):1252-8, 1258.e1. doi: 10.1016/j.jpeds.2012.11.038. Epub 2012 Dec 24.

15.

Differences in characteristics of dying children who receive and do not receive palliative care.

Keele L, Keenan HT, Sheetz J, Bratton SL.

Pediatrics. 2013 Jul;132(1):72-8. doi: 10.1542/peds.2013-0470. Epub 2013 Jun 10.

16.

A clinical audit of antithrombin concentrate use in a tertiary paediatric centre.

Kozul C, Newall F, Monagle P, Mertyn E, Ignjatovic V.

J Paediatr Child Health. 2012 Aug;48(8):681-4. doi: 10.1111/j.1440-1754.2012.02451.x. Epub 2012 Apr 19.

PMID:
22515204
17.

Antithrombin III supplementation on extracorporeal membrane oxygenation: impact on heparin dose and circuit life.

Byrnes JW, Swearingen CJ, Prodhan P, Fiser R, Dyamenahalli U.

ASAIO J. 2014 Jan-Feb;60(1):57-62. doi: 10.1097/MAT.0000000000000010.

PMID:
24296776
18.

Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA.

Borges AP, Campos MS, Pereira LR.

Int J Clin Pharm. 2013 Jun;35(3):425-31. doi: 10.1007/s11096-013-9755-2. Epub 2013 Feb 21.

PMID:
23430533
19.

Interhospital transport of children requiring extracorporeal membrane oxygenation support for cardiac dysfunction.

Cabrera AG, Prodhan P, Cleves MA, Fiser RT, Schmitz M, Fontenot E, McKamie W, Chipman C, Jaquiss RD, Imamura M.

Congenit Heart Dis. 2011 May-Jun;6(3):202-8. doi: 10.1111/j.1747-0803.2011.00506.x. Epub 2011 Mar 31.

PMID:
21450033
20.

Short- and intermediate-term survival after extracorporeal membrane oxygenation in children with cardiac disease.

Chrysostomou C, Morell VO, Kuch BA, O'Malley E, Munoz R, Wearden PD.

J Thorac Cardiovasc Surg. 2013 Aug;146(2):317-25. doi: 10.1016/j.jtcvs.2012.11.014. Epub 2012 Dec 8.

Items per page

Supplemental Content

Write to the Help Desk